With a legacy that spans more than 30 years in ophthalmology, Nova Eye Medical develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies designed to advance clinical outcomes and improve patient quality of life.
With its sales headquarters based in Fremont, California, Nova Eye Medical is supported by a global network of more than 50 distribution partners. Manufacturing facilities are located in Fremont, California and Dunedin, New Zealand.
At the heart of Nova Eye Medical is our iTrack™ canal based MIGS procedure, also known as ab-interno canaloplasty. The world’s only device indicated for viscodilation in the treatment of open-angle glaucoma, iTrack™ is helping to redefine the treatment of glaucoma in its early stages. iTrack™ can also be performed via an ab-externo approach to offer a highly effective, bleb-free alternative to traditional glaucoma surgery in the treatment of advanced glaucoma patients.
Acquired from world-leader Molteno Ophthalmic Ltd, the Molteno3® Glaucoma Drainage Device is a highly effective option for cases of severe and complex glaucoma and provides the added benefit of a simplified and faster surgical procedure.
Ellex is a registered trademark of Quantel Medical